Insulin-like growth factor-I:Vitronectin complex-induced changes in gene expression effect breast cell survival and migration

Endocrinology

Volumn 152, Issue 4, 2011, Pages 1388-1401

  Kashyap, Abhishek S ^a   Hollier, Brett G ^a   Manton, Kerry J ^a   Satyamoorthy, K ^b   Leavesley, David I ^a   Upton, Zee ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b MANIPAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 7; DOXORUBICIN; EPHRIN B2; GROWTH FACTOR; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; STRATIFIN; THROMBOPLASTIN; VITRONECTIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST; BREAST CANCER; CANCER GROWTH; CELL CYCLE; CELL MIGRATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SHARP 2 GENE;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VITRONECTIN;

EID: 79953182314     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0897     Document Type: Article

References (65)

1. Agurs-Collins T, Adams-Campbell LL, Kim KS, Cullen KJ 2000 Insulin-like growth factor-1 and breast cancer risk in postmenopausal African-American women. Cancer Detect Prev 24:199-206 (Pubitemid 30656726)
2. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N 1990 Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48-53 (Pubitemid 20029992)
3. Lann D, LeRoith D 2008 The role of endocrine insulin-like growth factor-I and insulin in breast cancer. J Mammary Gland Biol Neoplasia 13:371-379
4. Pollak M 2007 Insulin-like growth factor-related signaling and cancer development. Recent Results Cancer Res 174:49-53
5. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M 2004 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-1353
6. Samani AA, Yakar S, LeRoith D, Brodt P 2007 The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28:20-47 (Pubitemid 46220849)
7. Hollier BG, Kricker JA, Van Lonkhuyzen DR, Leavesley DI, Upton Z 2008 Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor. Endocrinology 149:1075-1090 (Pubitemid 351397938)
8. Rubini M, D'Ambrosio C, Carturan S, Yumet G, Catalano E, Shan S, Huang Z, Criscuolo M, Pifferi M, Baserga R 1999 Characterization of an antibody that can detect an activated IGF-I receptor in human cancers. Exp Cell Res 251:22-32 (Pubitemid 29406516)
9. Peyrat JP, Bonneterre J 1992 Type 1 IGF receptor in human breast diseases. Breast Cancer Res Treat 22:59-67
10. Gebauer G, Jäger W, Lang N 1998 mRNA expression of components of the insulin-like growth factor system in breast cancer cell lines, tissues, and metastatic breast cancer cells. Anticancer Res 18:1191-1195 (Pubitemid 28239662)
11. Resnik JL, Reichart DB, Huey K, Webster NJ, Seely BL 1998 Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Cancer Res 58:1159-1164 (Pubitemid 28183203)
12. Beattie J, McIntosh L, van der Walle CF 2010 Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiology. J Cell Physiol 224:605-611
13. Kricker JA, Towne CL, Firth SM, Herington AC, Upton Z 2003 Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Endocrinology 144:2807-2815 (Pubitemid 36819880)
14. Upton Z, Webb H, Hale K, Yandell CA, McMurtry JP, Francis GL, Ballard FJ 1999 Identification of vitronectin as a novel insulin-like growth factor-II binding protein. Endocrinology 140:2928-2931 (Pubitemid 32245176)
15. Kricker JA, Hyde CE, Van Lonkhuyzen DR, Hollier BG, Shooter GK, Leavesley DI, Herington AC, Upton Z 2010 Mechanistic investigations into interactions between IGF-I and IGFBPs and their impact on facilitating cell migration on vitronectin. Growth Factors 28:359-369
16. Hyde C, Hollier B, Anderson A, Harkin D, Upton Z 2004 Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration. J Invest Dermatol 122:1198-1206 (Pubitemid 38651095)
17. Hollier B, Harkin DG, Leavesley D, Upton Z 2005 Responses of keratinocytes to substrate-bound vitronectin: growth factor complexes. Exp Cell Res 305:221-232 (Pubitemid 40380668)
18. Forsten KE, Akers RM, San Antonio JD 2001 Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment. J Cell Physiol 189:356-365 (Pubitemid 33063303)
19. Gui Y, Murphy LJ 2001 Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma. J Clin Endocrinol Metab 86:2104-2110 (Pubitemid 32472927)
20. Ricort JM, Binoux M 2004 Insulin-like growth factor binding protein-3 stimulates phosphatidylinositol 3-kinase in MCF-7 breast carcinoma cells. Biochem Biophys Res Commun 314:1044-1049 (Pubitemid 38142389)
21. Noble A, Towne C, Chopin L, Leavesley D, Upton Z 2003 Insulin-like growth factor-II bound to vitronectin enhances MCF-7 breast cancer cell migration. Endocrinology 144:2417-2424 (Pubitemid 36629893)
22. Van Lonkhuyzen DR, Hollier BG, Shooter GK, Leavesley DI, Upton Z 2007 Chimeric vitronectin:insulin-like growth factor proteins enhance cell growth and migration through co-activation of receptors. Growth Factors 25:295-308 (Pubitemid 351194028)
23. Leavesley DI, Schwartz MA, Rosenfeld M, Cheresh DA 1993 Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 121:163-170 (Pubitemid 23097372)
24. Pirnia F, Schneider E, Betticher DC, Borner MM 2002 Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway. Cell Death Differ 9:905-914 (Pubitemid 35023606)
25. Ta HQ, Thomas KS, Schrecengost RS, Bouton AH 2008 A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells. Cancer Res 68:8796-8804
26. Mutch DM, Berger A, Mansourian R, Rytz A, Roberts MA 2002 The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data. BMC Bioinformatics 3:17
27. Dey BR, Frick K, Lopaczynski W, Nissley SP, Furlanetto RW 1996 Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10. Mol Endocrinol 10:631-641 (Pubitemid 26176271)
28. Craparo A, Freund R, Gustafson TA 1997 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J Biol Chem 272:11663-11669 (Pubitemid 27184180)
29. Horney MJ, Evangelista CA, Rosenzweig SA 2001 Synthesis and characterization of insulin-like growth factor (IGF)-1 photoprobes selective for the IGF-binding proteins (IGFBPS). photoaffinity labeling of the IGF-binding domain on IGFBP-2. J Biol Chem 276:2880-2889
30. Forbes BE, Hartfield PJ, McNeil KA, Surinya KH, Milner SJ, Cosgrove LJ, Wallace JC 2002 Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis. Eur J Biochem 269:961-968 (Pubitemid 34175417)
31. Milner SJ, Francis GL, Wallace JC, Magee BA, Ballard FJ 1995 Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties. Biochem J 308(Pt 3):865-871
32. Tomaskovic-Crook E, Thompson EW, Thiery JP 2009 Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res 11:213
33. Taipale J, Keski-Oja J 1997 Growth factors in the extracellular matrix. FASEB J 11:51-59 (Pubitemid 27076324)
34. Jones JI, Gockerman A, Busby Jr WH, Camacho-Hubner C, Clemmons DR 1993 Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol 121:679-687
35. Strange KS, Wilkinson D, Edin G, Emerman JT 2004 Mitogenic properties of insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and epidermal growth factor on human breast stromal cells in primary culture. Breast Cancer Res Treat 84:77-84 (Pubitemid 38393358)
36. Baserga R 1997 The path less traveled by. Endocrinology 138:2217-2218
37. Surmacz E 2000 Function of the IGF-I receptor in breast cancer. J Mammary Gland Biol Neoplasia 5:95-105
38. Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R 1995 Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res 55:3739-3741
39. Resnicoff M, Baserga R 1998 The role of the insulin-like growth factor I receptor in transformation and apoptosis. Ann NY Acad Sci 842:76-81 (Pubitemid 28227009)
40. Uhm JH, Dooley NP, Kyritsis AP, Rao JS, Gladson CL 1999 Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death. Clin Cancer Res 5:1587-1594 (Pubitemid 29282968)
41. Neuenschwander S, Roberts Jr CT, LeRoith D 1995 Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid. Endocrinology 136:4298-4303
42. Gladson CL, Cheresh DA 1991 Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88:1924-1932
43. Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM 2001 Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res 61:8730-8736 (Pubitemid 34013884)
44. Prueitt RL, Boersma BJ, Howe TM, Goodman JE, Thomas DD, Ying L, Pfiester CM, Yfantis HG, Cottrell JR, Lee DH, Remaley AT, Hofseth LJ, Wink DA, Ambs S 2007 Inflammation and IGF-I activate the Akt pathway in breast cancer. Int J Cancer 120:796-805 (Pubitemid 46175399)
45. Katz M, Amit I, Yarden Y 2007 Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta 1773:1161-1176 (Pubitemid 47125978)
46. Hay N 2005 The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8:179-183 (Pubitemid 41317589)
47. Scheid MP, Woodgett JR 2001 PKB/AKT: functional insights from genetic models. Nat Rev 2:760-768 (Pubitemid 33679838)
48. Dupont J, Khan J, Qu BH, Metzler P, Helman L, LeRoith D 2001 Insulin and IGF-I induce different patterns of gene expression in mouse fibroblast NIH-3T3 cells: identification by cDNA microarray analysis. Endocrinology 142:4969-4975 (Pubitemid 33022373)
49. Mulligan C, Rochford J, Denyer G, Stephens R, Yeo G, Freeman T, Siddle K, O'Rahilly S 2002 Microarray analysis of insulin and insulin-like growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1. J Biol Chem 277:42480-42487 (Pubitemid 35285614)
50. Kuemmerle JF, Zhou H, Bowers JG 2004 IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1 phase cell cycle proteins. Am J Physiol Gastrointest Liver Physiol 286:G412-G419 (Pubitemid 38250313)
51. Simpson MJ, Towne C, McElwain DLS, Upton Z 2010 Migration of breast cancer cells: Understanding the roles of volume exclusion and cell-to-cell adhesion. Phys Rev E Stat Nonlin Soft Matter Phys 82:041901
52. Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W 1998 A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 140:1241-1253 (Pubitemid 28128882)
53. Meyer S, Hafner C, Guba M, Flegel S, Geissler EK, Becker B, Koehl GE, Ors ó E, Landthaler M, Vogt T 2005 Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells. Int J Oncol 27:1197-1206
54. Chazaud B, Ricoux R, Christov C, Plonquet A, Gherardi RK, Barlovatz-Meimon G 2002 Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations. Am J Pathol 160:237-246 (Pubitemid 34052284)
55. Loskutoff DJ, Curriden SA, Hu G, Deng G 1999 Regulation of cell adhesion by PAI-1. APMIS 107:54-61 (Pubitemid 29133523)
56. Waltz DA, Natkin LR, Fujita RM, Wei Y, Chapman HA 1997 Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J Clin Invest 100:58-67 (Pubitemid 27311243)
57. Ruff CT, Giugliano R, Morrow DA 2006 Inhibition of tissue factor as a novel approach to anticoagulation in patients with coronary artery disease. Future Cardiol 2:85-91
58. Kumar SR, Singh J, Xia G, Krasnoperov V, Hassanieh L, Ley EJ, Scehnet J, Kumar NG, Hawes D, Press MF, Weaver FA, Gill PS 2006 Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol 169:279-293
59. Boudjelal M, Taneja R, Matsubara S, Bouillet P, Dolle P, Chambon P 1997 Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells. Genes Dev 11:2052-2065 (Pubitemid 27369100)
60. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ 1996 Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87:619-628 (Pubitemid 26386936)
61. Laronga C, Yang HY, Neal C, Lee MH 2000 Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 275:23106-23112 (Pubitemid 30646202)
62. Zhang Y, Karas M, Zhao H, Yakar S, LeRoith D 2004 14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation. J Biol Chem 279:34353-34360 (Pubitemid 39318060)
63. Chakrabarti J, Turley H, Campo L, Han C, Harris AL, Gatter KC, Fox SB 2004 The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br J Cancer 91:954-958 (Pubitemid 39273790)
64. Smith LM, Walsh PT, Rüdiger T, Cotter TG, Mc Carthy TV, Marx A, O'Connor R 2004 EphA3 is induced by CD28 and IGF-1 and regulates cell adhesion. Exp Cell Res 292:295-303 (Pubitemid 38018845)
65. Myers Jr MG, Sun XJ, White MF 1994 The IRS-1 signaling system. Trends Biochem Sci 19:289-293 (Pubitemid 24221949)